Goldstein Barbara A, Lenhardt Martin L, Shulman Abraham
Department of Otolaryngology, State University of New York, Downstate Medical Center, Brooklyn, New York 11203, USA.
Int Tinnitus J. 2005;11(1):14-22.
This study reports on the long-term benefit of ultra-high-frequency masking with the UltraQuiet device. A commercial product, UltraQuiet provides a new form of high-frequency bone conduction therapy. To assess its effectiveness in tinnitus treatment, we selected 15 patients with problematic tinnitus and randomly assigned them to three variations of the medical-audiological tinnitus patient protocol modified for the UltraQuiet study. We assessed tinnitus relief by questionnaires directed at weighing patient response to overall effectiveness, tinnitus loudness, tinnitus severity, and tinnitus annoyance. Additionally, we performed audiological measures (including pure-tone and speech audiometry, minimal masking levels, pitch and loudness matching, and residual inhibition). All patients showed some long-term gains, and most exhibited relief in at least one measurement parameter, providing support for the use of high-frequency vibration in the treatment of tinnitus.
本研究报告了使用UltraQuiet设备进行超高频掩蔽的长期益处。UltraQuiet是一种商业产品，提供了一种新形式的高频骨传导疗法。为了评估其在耳鸣治疗中的有效性，我们选择了15例耳鸣问题患者，并将他们随机分配到为UltraQuiet研究修改的医学-听力学耳鸣患者方案的三个变体中。我们通过针对衡量患者对总体疗效、耳鸣响度、耳鸣严重程度和耳鸣烦恼度的反应的问卷来评估耳鸣缓解情况。此外，我们还进行了听力学测量（包括纯音和言语听力测定、最小掩蔽水平、音高和响度匹配以及残余抑制）。所有患者均显示出一定的长期改善，并且大多数患者在至少一个测量参数上表现出缓解，这为在耳鸣治疗中使用高频振动提供了支持。
